In-depth PtdIns(3,4,5)P3 signalosome analysis identifies DAPP1 as a negative regulator of GPVI-driven platelet function

Blood Advances

Volumn 1, Issue 14, 2017, Pages 918-932

  Durrant, Tom N ^a   Hutchinson, James L ^a   Heesom, Kate J ^a   Anderson, Karen E ^b   Stephens, Len R ^b   Hawkins, Phillip T ^b   Marshall, Aaron J ^c,d   Moore, Samantha F ^a   Hers, Ingeborg ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BABRAHAM INSTITUTE   (United Kingdom)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85030675325     PISSN: 24739529     EISSN: 24739537     Source Type: Journal    
DOI: 10.1182/bloodadvances.2017005173     Document Type: Article

References (100)

1. Willoughby S, Holmes A, Loscalzo J. Platelets and cardiovascular disease. Eur J Cardiovasc Nurs. 2002;1(4):273-288.
2. Goggs R, Poole AW. Platelet signaling-a primer. J Vet Emerg Crit Care (San Antonio). 2012;22(1):5-29.
3. Hers I. Insulin-like growth factor-1 potentiates platelet activation via the IRS/PI3Kalpha pathway. Blood. 2007;110(13):4243-4252.
4. Blair TA, Moore SF, Hers I. Circulating primers enhance platelet function and induce resistance to antiplatelet therapy. J Thromb Haemost. 2015;13(8): 1479-1493.
5. Blair T, Moore SF, Hers I. Deletion of PI3K P110A results in enhanced primer-mediated regulation of platelet function and thrombosis. J Thromb Haemost. 2015;13:416.
6. Laurent PA, Severin S, Gratacap MP, Payrastre B. Class I PI 3-kinases signaling in platelet activation and thrombosis: PDK1/Akt/GSK3 axis and impact of PTEN and SHIP1. Adv Biol Regul. 2014;54:162-174.
7. Guidetti GF, Canobbio I, Torti M. PI3K/Akt in platelet integrin signaling and implications in thrombosis. Adv Biol Regul. 2015;59:36-52.
8. Jackson SP, Schoenwaelder SM, Goncalves I, et al. PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med. 2005;11(5):507-514.
9. Martin V, Guillermet-Guibert J, Chicanne G, et al. Deletion of the p110beta isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo. Blood. 2010;115(10):2008-2013.
10. Canobbio I, Stefanini L, Cipolla L, et al. Genetic evidence for a predominant role of PI3Kbeta catalytic activity in ITAM- and integrin-mediated signaling in platelets. Blood. 2009;114(10):2193-2196.
11. Nylander S, Kull B, Björkman JA, et al. Human target validation of phosphoinositide 3-kinase (PI3K)b: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kb inhibitor. J Thromb Haemost. 2012;10(10):2127-2136.
12. Nylander S, Wågberg F, Andersson M, Skärby T, Gustafsson D. Exploration of efficacy and bleeding with combined phosphoinositide 3-kinase b inhibition and aspirin in man. J Thromb Haemost. 2015;13(8):1494-1502.
13. Laurent PA, Séverin S, Hechler B, Vanhaesebroeck B, Payrastre B, Gratacap MP. Platelet PI3Kb and GSK3 regulate thrombus stability at a high shear rate. Blood. 2015;125(5):881-888.
14. Torti M. PI3Kb inhibition: all that glitters is not gold. Blood. 2015;125(5):750-751.
15. Thomas D, Powell JA, Green BD, et al. Protein kinase activity of phosphoinositide 3-kinase regulates cytokine-dependent cell survival. PLoS Biol. 2013; 11(3):e1001515.
16. Hirsch E, Braccini L, Ciraolo E, Morello F, Perino A. Twice upon a time: PI3K’s secret double life exposed. Trends Biochem Sci. 2009;34(5):244-248.
17. Hawkins PT, Anderson KE, Davidson K, Stephens LR. Signalling through class I PI3Ks in mammalian cells. Biochem Soc Trans. 2006;34(Pt 5):647-662.
18. Leslie NR, Dixon MJ, Schenning M, Gray A, Batty IH. Distinct inactivation of PI3K signalling by PTEN and 5-phosphatases. Adv Biol Regul. 2012;52(1): 205-213.
19. Krugmann S, Anderson KE, Ridley SH, et al. Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol Cell. 2002;9(1):95-108.
20. Catimel B, Yin MX, Schieber C, et al. PI(3,4,5)P3 Interactome. J Proteome Res. 2009;8(7):3712-3726.
21. Park WS, Heo WD, Whalen JH, et al. Comprehensive identification of PIP3-regulated PH domains from C. elegans to H. sapiens by model prediction and live imaging. Mol Cell. 2008;30(3):381-392.
22. Hers I, Vincent EE, Tavaré JM. Akt signalling in health and disease. Cell Signal. 2011;23(10):1515-1527.
23. Chen X, Zhang Y, Wang Y, et al. PDK1 regulates platelet activation and arterial thrombosis. Blood. 2013;121(18):3718-3726.
24. Quek LS, Bolen J, Watson SP. A role for Bruton’s tyrosine kinase (Btk) in platelet activation by collagen. Curr Biol. 1998;8(20):1137-1140.
25. Stefanini L, Paul DS, Robledo RF, et al. RASA3 is a critical inhibitor of RAP1-dependent platelet activation. J Clin Invest. 2015;125(4):1419-1432.
26. Zeiler M, Moser M, Mann M. Copy number analysis of the murine platelet proteome spanning the complete abundance range. Mol Cell Proteomics. 2014; 13(12):3435-3445.
27. Burkhart JM, Vaudel M, Gambaryan S, et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood. 2012;120(15):e73-e82.
28. Senis Y, García A. Platelet proteomics: state of the art and future perspective. Methods Mol Biol. 2012;788:367-399.
29. Anderson KE, Lipp P, Bootman M, et al. DAPP1 undergoes a PI 3-kinase-dependent cycle of plasma-membrane recruitment and endocytosis upon cell stimulation. Curr Biol. 2000;10(22):1403-1412.
30. Dowler S, Currie RA, Downes CP, Alessi DR. DAPP1: a dual adaptor for phosphotyrosine and 3-phosphoinositides. Biochem J. 1999;342(Pt 1):7-12.
31. Marshall AJ, Niiro H, Lerner CG, et al. A novel B lymphocyte-associated adaptor protein, Bam32, regulates antigen receptor signaling downstream of phosphatidylinositol 3-kinase. J Exp Med. 2000;191(8):1319-1332.
32. Rao VR, Corradetti MN, Chen J, et al. Expression cloning of protein targets for 3-phosphorylated phosphoinositides. J Biol Chem. 1999;274(53): 37893-37900.
33. Zhang TT, Li H, Cheung SM, et al. Phosphoinositide 3-kinase-regulated adapters in lymphocyte activation. Immunol Rev. 2009;232(1):255-272.
34. Hunter RW, Hers I. Insulin/IGF-1 hybrid receptor expression on human platelets: consequences for the effect of insulin on platelet function. J Thromb Haemost. 2009;7(12):2123-2130.
35. Vizcaíno JA, Csordas A, del-Toro N, et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. 2016;44(D1):D447-D456.
36. Han A, Saijo K, Mecklenbräuker I, Tarakhovsky A, Nussenzweig MC. Bam32 links the B cell receptor to ERK and JNK and mediates B cell proliferation but not survival. Immunity. 2003;19(4):621-632.
37. Williams CM, Savage JS, Harper MT, Moore SF, Hers I, Poole AW. Identification of roles for the SNARE-associated protein, SNAP29, in mouse platelets. Platelets. 2016;27(4):286-294.
38. Walsh TG, Harper MT, Poole AW. SDF-1a is a novel autocrine activator of platelets operating through its receptor CXCR4. Cell Signal. 2015;27(1): 37-46.
39. Moore SF, Hunter RW, Hers I. mTORC2 Protein-mediated protein kinase B (Akt) serine 473 phosphorylation is not required for Akt1 activity in human platelets [published correction appears in J Biol Chem. 201;286(35):31062]. J Biol Chem. 2011;286(28):24553-24560.
40. Moore SF, van den Bosch MTJ, Hunter RW, Sakamoto K, Poole AW, Hers I. Dual regulation of glycogen synthase kinase 3 (GSK3)a/b by protein kinase C (PKC)a and Akt promotes thrombin-mediated integrin aIIbb3 activation and granule secretion in platelets. J Biol Chem. 2013;288(6):3918-3928.
41. Clark J, Anderson KE, Juvin V, et al. Quantification of PtdInsP3 molecular species in cells and tissues by mass spectrometry. Nat Methods. 2011;8(3): 267-272.
42. Kielkowska A, Niewczas I, Anderson KE, et al. A new approach to measuring phosphoinositides in cells by mass spectrometry. Adv Biol Regul. 2014;54: 131-141.
43. Battram AM, Durrant TN, Agbani EO, et al. The phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) binder Rasa3 regulates phosphoinositide 3-kinase (PI3K)-dependent integrin aIIbb3 outside-in signaling. J Biol Chem. 2017;292(5):1691-1704.
44. Ahrné E, Molzahn L, Glatter T, Schmidt A. Critical assessment of proteome-wide label-free absolute abundance estimation strategies. Proteomics. 2013; 13(17):2567-2578.
45. Dowler S, Currie RA, Campbell DG, et al. Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities. Biochem J. 2000;351(Pt 1):19-31.
46. Venkateswarlu K, Oatey PB, Tavaré JM, Jackson TR, Cullen PJ. Identification of centaurin-alpha1 as a potential in vivo phosphatidylinositol 3,4,5-trisphosphate-binding protein that is functionally homologous to the yeast ADP-ribosylation factor (ARF) GTPase-activating protein, Gcs1. Biochem J. 1999;340(Pt 2):359-363.
47. Jungmichel S, Sylvestersen KB, Choudhary C, Nguyen S, Mann M, Nielsen ML. Specificity and commonality of the phosphoinositide-binding proteome analyzed by quantitative mass spectrometry. Cell Reports. 2014;6(3):578-591.
48. Klarlund JK, Guilherme A, Holik JJ, Virbasius JV, Chawla A, Czech MP. Signaling by phosphoinositide-3,4,5-trisphosphate through proteins containing pleckstrin and Sec7 homology domains. Science. 1997;275(5308):1927-1930.
49. Dixon MJ, Gray A, Boisvert FM, et al. A screen for novel phosphoinositide 3-kinase effector proteins. Mol Cell Proteomics. 2011;10(4):M110.003178.
50. Dart AE, Tollis S, Bright MD, Frankel G, Endres RG. The motor protein myosin 1G functions in FcgR-mediated phagocytosis. J Cell Sci. 2012;125(Pt 24): 6020-6029.
51. Côté JF, Motoyama AB, Bush JA, Vuori K. A novel and evolutionarily conserved PtdIns(3,4,5)P3-binding domain is necessary for DOCK180 signalling. Nat Cell Biol. 2005;7(8):797-807.
52. Cozier GE, Lockyer PJ, Reynolds JS, et al. GAP1IP4BP contains a novel group I pleckstrin homology domain that directs constitutive plasma membrane association. J Biol Chem. 2000;275(36):28261-28268.
53. Laurin M, Côté JF. Insights into the biological functions of Dock family guanine nucleotide exchange factors. Genes Dev. 2014;28(6):533-547.
54. Craig HE, Coadwell J, Guillou H, Vermeren S. ARAP3 binding to phosphatidylinositol-(3,4,5)-trisphosphate depends on N-terminal tandem PH domains and adjacent sequences. Cell Signal. 2010;22(2):257-264.
55. Fayngerts SA, Wu J, Oxley CL, et al. TIPE3 is the transfer protein of lipid second messengers that promote cancer. Cancer Cell. 2014;26(4):465-478.
56. Liu P, Gan W, Chin YR, et al. PtdIns(3,4,5)P3-dependent activation of the mTORC2 kinase complex. Cancer Discov. 2015;5(11):1194-1209.
57. Welch HCE, Coadwell WJ, Ellson CD, et al. P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac. Cell. 2002;108(6):809-821.
58. Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57.
59. Maere S, Heymans K, Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics. 2005;21(16):3448-3449.
60. Snel B, Lehmann G, Bork P, Huynen MA. STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res. 2000;28(18):3442-3444.
61. Gaidarov I, Chen Q, Falck JR, Reddy KK, Keen JH. A functional phosphatidylinositol 3,4,5-trisphosphate/phosphoinositide binding domain in the clathrin adaptor AP-2 alpha subunit. Implications for the endocytic pathway. J Biol Chem. 1996;271(34):20922-20929.
62. Klarlund JK, Holik J, Chawla A, Park JG, Buxton J, Czech MP. Signaling complexes of the FERM domain-containing protein GRSP1 bound to ARF exchange factor GRP1. J Biol Chem. 2001;276(43):40065-40070.
63. DiNitto JP, Lee MT, Malaby AW, Lambright DG. Specificity and membrane partitioning of Grsp1 signaling complexes with Grp1 family Arf exchange factors. Biochemistry. 2010;49(29):6083-6092.
64. van den Bosch MTJ, Poole AW, Hers I. Cytohesin-2 phosphorylation by protein kinase C relieves the constitutive suppression of platelet dense granule secretion by ADP-ribosylation factor 6. J Thromb Haemost. 2014;12(5):726-735.
65. Rameh LE, Arvidsson A, Carraway KL III, et al. A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J Biol Chem. 1997;272(35):22059-22066.
66. Cozier GE, Bouyoucef D, Cullen PJ. Engineering the phosphoinositide-binding profile of a class I pleckstrin homology domain. J Biol Chem. 2003; 278(41):39489-39496.
67. Hou S, Pauls SD, Liu P, Marshall AJ. The PH domain adaptor protein Bam32/DAPP1 functions in mast cells to restrain FceRI-induced calcium flux and granule release. Mol Immunol. 2010;48(1-3):89-97.
68. Fournier E, Isakoff SJ, Ko K, et al. The B cell SH2/PH domain-containing adaptor Bam32/DAPP1 is required for T cell-independent II antigen responses. Curr Biol. 2003;13(21):1858-1866.
69. Zhang TT, Al-Alwan M, Marshall AJ. The pleckstrin homology domain adaptor protein Bam32/DAPP1 is required for germinal center progression. J Immunol. 2010;184(1):164-172.
70. Gratacap MP, Severin S, Chicanne G, Plantavid M, Payrastre B. Different roles of SHIP1 according to the cell context: the example of blood platelets. Adv Enzyme Regul. 2008;48:240-252.
71. Hawkins PT, Stephens LR. Emerging evidence of signalling roles for PI(3,4)P2 in Class I and II PI3K-regulated pathways. Biochem Soc Trans. 2016; 44(1):307-314.
72. Lundmark R, Carlsson SR. Sorting nexin 9 participates in clathrin-mediated endocytosis through interactions with the core components. J Biol Chem. 2003;278(47):46772-46781.
73. Yarar D, Surka MC, Leonard MC, Schmid SL. SNX9 activities are regulated by multiple phosphoinositides through both PX and BAR domains. Traffic. 2008;9(1):133-146.
74. Stephens LR, Anderson KE, Hawkins PT. Src family kinases mediate receptor-stimulated, phosphoinositide 3-kinase-dependent, tyrosine phosphorylation of dual adaptor for phosphotyrosine and 3-phosphoinositides-1 in endothelial and B cell lines. J Biol Chem. 2001;276(46): 42767-42773.
75. Dowler S, Montalvo L, Cantrell D, Morrice N, Alessi DR. Phosphoinositide 3-kinase-dependent phosphorylation of the dual adaptor for phosphotyrosine and 3-phosphoinositides by the Src family of tyrosine kinase. Biochem J. 2000;349(Pt 2):605-610.
76. Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood. 2003;102(2):449-461.
77. Manganaro D, Consonni A, Guidetti GF, et al. Activation of phosphatidylinositol 3-kinase b by the platelet collagen receptors integrin a2b1 and GPVI: The role of Pyk2 and c-Cbl. Biochim Biophys Acta. 2015;1853(8):1879-1888.
78. Kim S, Mangin P, Dangelmaier C, et al. Role of phosphoinositide 3-kinase beta in glycoprotein VI-mediated Akt activation in platelets. J Biol Chem. 2009; 284(49):33763-33772.
79. Banfić H, Downes CP, Rittenhouse SE. Biphasic activation of PKBalpha/Akt in platelets. Evidence for stimulation both by phosphatidylinositol 3,4-bisphosphate, produced via a novel pathway, and by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1998;273(19):11630-11637.
80. Gratacap MP, Payrastre B, Viala C, Mauco G, Plantavid M, Chap H. Phosphatidylinositol 3,4,5-trisphosphate-dependent stimulation of phospholipase C-gamma2 is an early key event in FcgammaRIIA-mediated activation of human platelets. J Biol Chem. 1998;273(38):24314-24321.
81. Pettitt TR, Dove SK, Lubben A, Calaminus SDJ, Wakelam MJO. Analysis of intact phosphoinositides in biological samples. J Lipid Res. 2006;47(7): 1588-1596.
82. Anderson KE, Juvin V, Clark J, Stephens LR, Hawkins PT. Investigating the effect of arachidonate supplementation on the phosphoinositide content of MCF10a breast epithelial cells. Adv Biol Regul. 2016;62:18-24.
83. Anderson KE, Kielkowska A, Durrant TN, et al. Lysophosphatidylinositol-acyltransferase-1 (LPIAT1) is required to maintain physiological levels of PtdIns and PtdInsP(2) in the mouse. PLoS One. 2013;8(3):e58425.
84. Rowland MM, Bostic HE, Gong D, et al. Phosphatidylinositol 3,4,5-trisphosphate activity probes for the labeling and proteomic characterization of protein binding partners. Biochemistry. 2011;50(51):11143-11161.
85. Shirai T, Tanaka K, Terada Y, et al. Specific detection of phosphatidylinositol 3,4,5-trisphosphate binding proteins by the PIP3 analogue beads: an application for rapid purification of the PIP3 binding proteins. Biochim Biophys Acta. 1998;1402(3):292-302.
86. Zhang P, Wang Y, Sesaki H, Iijima M. Proteomic identification of phosphatidylinositol (3,4,5) triphosphate-binding proteins in Dictyostelium discoideum. Proc Natl Acad Sci USA. 2010;107(26):11829-11834.
87. Vasudevan KM, Barbie DA, Davies MA, et al. AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell. 2009;16(1):21-32.
88. Costa C, Ebi H, Martini M, et al. Measurement of PIP3 levels reveals an unexpected role for p110b in early adaptive responses to p110a-specific inhibitors in luminal breast cancer. Cancer Cell. 2015;27(1):97-108.
89. Kroner C, Eybrechts K, Akkerman JWN. Dual regulation of platelet protein kinase B. J Biol Chem. 2000;275(36):27790-27798.
90. Aslan JE, McCarty OJT. Rho GTPases in platelet function. J Thromb Haemost. 2013;11(1):35-46.
91. Huang Y, Joshi S, Xiang B, et al. Arf6 controls platelet spreading and clot retraction via integrin aIIbb3 trafficking. Blood. 2016;127(11):1459-1467.
92. Pleines I, Hagedorn I, Gupta S, et al. Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in hemostasis and thrombosis. Blood. 2012;119(4):1054-1063.
93. Gambardella L, Hemberger M, Hughes B, Zudaire E, Andrews S, Vermeren S. PI3K signaling through the dual GTPase-activating protein ARAP3 is essential for developmental angiogenesis. Sci Signal. 2010;3(145):ra76.
94. Kunisaki Y, Nishikimi A, Tanaka Y, et al. DOCK2 is a Rac activator that regulates motility and polarity during neutrophil chemotaxis. J Cell Biol. 2006; 174(5):647-652.
95. Badour K, McGavin MKH, Zhang J, et al. Interaction of the Wiskott-Aldrich syndrome protein with sorting nexin 9 is required for CD28 endocytosis and cosignaling in T cells. Proc Natl Acad Sci USA. 2007;104(5):1593-1598.
96. Sommers CL, Gurson JM, Surana R, et al. Bam32: a novel mediator of Erk activation in T cells. Int Immunol. 2008;20(7):811-818.
97. Onyilagha C, Jia P, Jayachandran N, et al. The B cell adaptor molecule Bam32 is critically important for optimal antibody response and resistance to Trypanosoma congolense infection in mice. PLoS Negl Trop Dis. 2015;9(4):e0003716.
98. Niiro H, Allam A, Stoddart A, Brodsky FM, Marshall AJ, Clark EA. The B lymphocyte adaptor molecule of 32 kilodaltons (Bam32) regulates B cell antigen receptor internalization. J Immunol. 2004;173(9):5601-5609.
99. Allam A, Niiro H, Clark EA, Marshall AJ. The adaptor protein Bam32 regulates Rac1 activation and actin remodeling through a phosphorylation-dependent mechanism. J Biol Chem. 2004;279(38):39775-39782.
100. Miao B, Skidan I, Yang J, et al. Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains. Proc Natl Acad Sci USA. 2010;107(46):20126-20131.